Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Explore the question of which is better for daily expenses: cash back or points. Make informed choices to maximize your rewards potential.
27,346 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
The CFPB signals that immigration status could influence a borrower's ability to repay a loan, potentially reshaping ...
With $2,000 to invest, you can build a growth-focused starter portfolio. This guide shows the smartest growth stocks ...
Vertex’s $10 billion cash bid for Crinetics sparked a sharp rally, lifting the stock nearly to the offer price as tra...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...
As earnings season winds down, March can be a smart time to add leading tech stocks to your portfolio. Explore three ...
Sprott just bought a large stake in its own stock. What does this mean for investors? This guide breaks down the impl...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
A key inflation report this Friday could markets move and set the tone for 2026. This guide breaks down what to watch...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...